Zhu Y, Ding Z, Wang Y, Wu Q, Chen D, Wang L, et al. BME-free primary patient-specific organoids obtained with a one-day mimicking method to replicate the corresponding tumor for personalized treatment options. Front Oncol. 2023;13:1239957 pubmed publisher

He L, Zhao J, Li H, Xie B, Xu L, Huang G, et al. Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy. Adv Sci (Weinh). 2023;10:e2202519 pubmed publisher

Wang G, Zhang Z, Zhong K, Wang Z, Yang N, Tang X, et al. CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma. Mol Ther. 2023;31:134-153 pubmed publisher

Siepe D, Henneberg L, Wilson S, Hess G, Bassik M, Zinn K, et al. Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform. elife. 2022;11: pubmed publisher

Singh S, Murillo G, RICHNER J, Singh S, Berleth E, Kumar V, et al. A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers. Int J Mol Sci. 2022;23: pubmed publisher

Holokai L, Chakrabarti J, Lundy J, Croagh D, Adhikary P, Richards S, et al. Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2020;12: pubmed publisher